The MAPK Pathway as a Therapeutic Target in Cancer Research

Article   Nov 30, 2017 | by Jack Rudd, Senior Editor for Technology Networks

 
The MAPK Pathway as a Therapeutic Target in Cancer Research

Jack Rudd

Senior Editor

 
 
 

RELATED ARTICLES

How We Tackle Antibiotic Resistance Now

Article

The fight against antibiotic resistance is real and is something we all have a responsibility in tackling. In fact, Antibiotic resistance kills an estimated 700,000 people each year and has fuelled the re-emergence of illnesses that had become a rarity in many parts of the world.

READ MORE

The Cancer Moonshot 2020: Then, Now & the Future

Article

Since the launch of the project, patients, caregivers, doctors, cancer centers, regulators and others have been hard at work to drive cancer research and treatment forward in a race to beat the disease.

READ MORE

Liquid Biopsies Coming of Age

Article

Based on the analysis of cells, genes, and chemical signals in body fluids, liquid biopsies provide timely, actionable information on disease states while eliminating the high cost and risks of tissue biopsies. Gene amplification through polymerase chain reaction and related techniques offer these benefits with the added advantage of amplifying low-abundance species. This article looks at the state of the art in PCR-based liquid biopsies, including a discussion of the technique's limitations.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE